drugset
Drugs / GD2 CAR modified Tri-virus specific cytotoxic t-cells
last change Jan 2015 re-read 3 minutes ago

GD2 CAR modified Tri-virus specific cytotoxic t-cells

Cell therapy

Developed for
neuroblastoma
Investigated by
Center for Cell and Gene Therapy, Baylor College of Medicine · Children's Mercy Hospital Kansas City

Trials 1

today NCT01460901 · Ph 1
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01460901 Oct 2012 → Jan 2015 neuroblastoma Children's Mercy Hospital Kansas City Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GD2 CAR modified Tri-virus specific cytotoxic t-cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT01460901 ↗
Action Deplete “carry the capability of killing tumor cells through their transduced receptor” NCT01460901 ↗
Modality Cell therapy “gene modified allogeneic virus specific T lymphocytes” NCT01460901 ↗